Randomized phase IIIb trial evaluating the continuation of bevacizumab beyond disease progression in patients with advanced non-squamous non-small-cell lung cancer after first-line treatment with bevacizumab plus platinum-based chemotherapy: treatment rationale and protocol dynamics of the AvaALL (MO22097) trial.

Gridelli C;Bennouna J;de Castro J;Dingemans AM;Griesinger F;Grossi F;Rossi A;Thatcher N;Wong EK;Langer C.

2011-01-01